SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunex -- Ignore unavailable to you. Want to Upgrade?


To: Guy Gordon who wrote (314)5/6/1999 7:47:00 PM
From: LemurHouse  Read Replies (1) | Respond to of 656
 
"...Use what works for you, what you have the time for, and what fits your psychology..."

I agree completely! Good luck with your trading.

Cheers.



To: Guy Gordon who wrote (314)5/10/1999 5:18:00 PM
From: Nelson Chang  Respond to of 656
 
*NEWS* for Monday May 10 after the close:

~Immunex to seek expanded label for Enbrel - Reuters Securities - 4:49 pm
~Immunex and Wyeth Ayerst Announce Label Update for ENBREL(R) - PR Newswire - 4:11 pm
~Alert: Immunex Says Plans to Seek Expanded Label for Enbrel in Q3 - Reuters Securities - 4:10 pm
~Alert: Immunex Says Results Positive in Enbrel Trial for Early Arthritis - Reuters Securities - 4:09 pm
~Positive Results of Pivotal Phase III Trial With ENBREL(R) in Patients With Early, Active Rheumatoid Arthritis - PR Newswire - 4:04 pm

The Yahoo link is at biz.yahoo.com